Physician profile
Abhishek Bhardwaj
NPI 1578844783
$109,952.85
in general payments reported to CMS, 2019-2025
32 companies · $106K in 2025
The $106K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2022: $413 · 2023: $1,284 · 2024: $2,230 · 2025: $106K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $89K · Travel and Lodging: $12K · Food and Beverage: $8,081 · Education: $197 · Gift: $17.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $88,690.00 |
| Travel and Lodging | $12,436.98 |
| Food and Beverage | $8,081.19 |
| Education | $197.36 |
| Gift | $17.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $62,195.53 | 2022-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $44,445.63 | 2019-2025 | Breztri, Tezspire, Airsupra |
| Inari Medical, INC. | $402.55 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Actelion Pharmaceuticals US, INC. | $394.65 | 2024 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $343.69 | 2023-2025 | Ofev |
| Stryker Corporation | $287.07 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowstasis |
| Grifols USA, LLC | $207.94 | 2022-2025 | Prolastin-C Liquid |
| Amgen INC. | $207.03 | 2023-2025 | Krystexxa, Tezspire, Evenity |
| Genentech USA, INC. | $134.35 | 2019-2022 | |
| Ucb, INC. | $134.27 | 2025 | Bimzelx |
| Abbvie INC. | $127.07 | 2023-2025 | Ubrelvy |
| Baxter Healthcare | $127.02 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Verona Pharma, INC. | $120.19 | 2025 | Ohtuvayre |
| Collegium Pharmaceutical, INC. | $115.16 | 2024-2025 | Belbuca |
| Regeneron Healthcare Solutions, INC. | $96.12 | 2023 | Dupixent |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $69.57 | 2025 | Arikayce |
| Janssen Biotech, INC. | $64.17 | 2024 | Tremfya |
| Mylan Specialty L.P. | $56.18 | 2023-2024 | Yupelri |
| Genzyme Corporation | $55.89 | 2023-2025 | |
| Electromed, INC. | $47.64 | 2023-2024 | Smartvest |
| Pfizer INC. | $38.35 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.36 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $33.10 | 2025 | |
| Pulmonx Corporation | $32.76 | 2024 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Boston Scientific Corporation | $32.11 | 2024 | Watchman Flx |
| Merck Sharp & Dohme LLC | $28.94 | 2023 | Keytruda |
| Viatris Specialty LLC | $24.85 | 2025 | Yupelri |
| Fresenius Kabi USA, LLC | $24.39 | 2023 | |
| Valinor Pharma, LLC | $19.99 | 2023 | Movantik |
| Masimo Corporation | $19.07 | 2023 | Patient Safetynet System |
| Depuy Synthes Sales INC. | $16.27 | 2024 | Orthovisc |
| Novo Nordisk INC | $15.94 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhishek Bhardwaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.